4-羟基-6-羧基吲哚 | 40990-52-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 4-羟基-6-羧基吲哚
• 英文名称: 4-hydroxy-1H-6-indolecarboxylic acid
• 英文别名: 4-hydroxy-1H-indole-6-carboxylic acid；4-Hydroxy-indol-6-carbonsaeure；4-hydroxy-indole-6-carboxylic acid
• CAS: 40990-52-1
• 化学式: C₉H₇NO₃
• mdl: MFCD04973988
• 分子量: 177.159
• InChiKey: TXZOAKBAZXCPGT-UHFFFAOYSA-N

物化性质

• 沸点：
  517.6±35.0 °C(Predicted)
• 密度：
  1.570±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  73.3
• 氢给体数：
  3
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  在 sodium hydroxide 作用下， 以 甲醇 为溶剂， 生成 4-羟基-6-羧基吲哚
  参考文献：
  名称：

  Fuganti, Claudio; Serra, Stefano, Journal of Chemical Research, Miniprint, 1998, # 10, p. 2769 - 2782

  摘要：

  DOI：

文献信息

• PYRIMIDINYL METHYL INDOLE DERIVATIVES WITH ANTIBACTERIAL ACTIVITY
  申请人：Basilea Pharmaceutica AG

  公开号：EP1280796A1

  公开（公告）日：2003-02-05
• [EN] PYRIMIDINYL METHYL INDOLE DERIVATIVES WITH ANTIBACTERIAL ACTIVITY<br/>[FR] DERIVES DE PYRIMIDINYL METHYL INDOLE A ACTIVITE ANTIBACTERIENNE
  申请人：HOFFMANN LA ROCHE

  公开号：WO2001083474A1

  公开（公告）日：2001-11-08

  This invention relates to indole derivatives of the general formula (I) wherein R1 is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, alkylsulfonyl, cycloalkylsulfonyl, cycloalkylalkylsulfonyl, dialkylsulfamoyl, N-cycloalkyl-N-alkylsulfamoyl, heterocyclylalkyl or phenylalkyl; R2 is hydrogen, halogen, alkyl, alkanoyl, phenyl, phenylalkyl or heterocyclylalkyl; R3 is hydrogen, alkyl; and R4 is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, alkylsulfonyl, cycloalkylsulfonyl, cycloalkylalkylsulfonyl, dialkylsulfamoyl, N-cycloalkyl-N-alkylsulfamoyl, heterocyclylalkyl, or phenylalkyl; and pharmaceutically acceptable acid addition salts of these compounds, there use as therapeutically active substances; medicaments based on these substances, optionally in combination with sulphonamides, and their production; the use of these substances as medicaments and for the production of antibacterially-active medicaments; as well as the manufacture of the compounds of formula (I) and their pharmaceutically acceptable acid addition salts and intermediates for their manufacture.
• Fuganti, Claudio; Serra, Stefano, Journal of Chemical Research, Miniprint, 1998, # 10, p. 2769 - 2782
  作者：Fuganti, Claudio、Serra, Stefano

  DOI：——

  日期：——